Morphic Holding Inc (MORF)
29.26
-0.23
(-0.78%)
USD |
NASDAQ |
May 22, 16:00
29.27
+0.01
(+0.03%)
After-Hours: 20:00
Morphic 1 Year Total Returns (Daily): -48.73% for May 22, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 22, 2024 | -48.73% |
May 21, 2024 | -48.24% |
May 20, 2024 | -46.62% |
May 17, 2024 | -48.24% |
May 16, 2024 | -41.32% |
May 15, 2024 | -47.46% |
May 14, 2024 | -50.54% |
May 13, 2024 | -49.98% |
May 10, 2024 | -50.39% |
May 09, 2024 | -50.21% |
May 08, 2024 | -46.50% |
May 07, 2024 | -45.29% |
May 06, 2024 | -44.87% |
May 03, 2024 | -41.59% |
May 02, 2024 | -40.79% |
May 01, 2024 | -43.37% |
April 30, 2024 | -42.30% |
April 29, 2024 | -40.82% |
April 26, 2024 | -38.98% |
April 25, 2024 | -40.09% |
April 24, 2024 | -36.39% |
April 23, 2024 | -35.85% |
April 22, 2024 | -36.41% |
April 19, 2024 | -37.41% |
April 18, 2024 | -37.42% |
Date | Value |
---|---|
April 17, 2024 | -34.32% |
April 16, 2024 | -19.60% |
April 15, 2024 | -14.81% |
April 12, 2024 | -19.65% |
April 11, 2024 | -14.74% |
April 10, 2024 | -14.97% |
April 09, 2024 | -10.37% |
April 08, 2024 | -12.35% |
April 05, 2024 | -13.37% |
April 04, 2024 | -16.29% |
April 03, 2024 | -16.49% |
April 02, 2024 | -15.25% |
April 01, 2024 | -12.57% |
March 28, 2024 | -5.93% |
March 27, 2024 | -8.46% |
March 26, 2024 | -11.93% |
March 25, 2024 | -13.62% |
March 22, 2024 | -13.60% |
March 21, 2024 | -14.06% |
March 20, 2024 | -17.47% |
March 19, 2024 | -18.94% |
March 18, 2024 | -19.99% |
March 15, 2024 | -18.32% |
March 14, 2024 | -20.67% |
March 13, 2024 | -20.00% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-68.75%
Minimum
Jun 13 2022
495.1%
Maximum
Mar 16 2021
46.96%
Average
22.29%
Median
1 Year Total Returns (Daily) Benchmarks
Keros Therapeutics Inc | 4.48% |
NovaBay Pharmaceuticals Inc | -80.31% |
Palatin Technologies Inc | -17.41% |
iBio Inc | -87.87% |
Theriva Biologics Inc | -46.76% |